"Ladies and gentlemen of the jury," began the PAINWeek 2016 speaker, in mock trial defense of a physician for over-prescribing opioid meds.
A PAINWeek 2016 expert panel gave attendees behind-the-scenes insight into the process behind the CDC's final recommendations.
Four studies presented at PAINWeek 2016 review the success of abuse-deterrent opioid formulations in stemming abuse and non-medical use.
At PAINWeek 2016, a session on abuse-deterrent formulations underscored that this drug class will never be free from abuse potential.
A PAINWeek audience experienced behavioral Rx during a presentation on effective non-drug treatment for migraine.